Opportunities for clinicians

At The Institute of Cancer Research, London, we offer clinicians a variety of opportunities – from a taught master's course in Oncology, to fellowships providing protected time for research, and higher research degrees.

Clinicians make up one-third of research team leaders at the ICR. This essential link between basic scientific research and clinical practice helps to get treatments into patients sooner, while ensuring that clinical knowledge is fed back to researchers, who can then develop more effective treatments.

patient-and-clinician

 


MSc in Oncology

Our MSc in Oncology is a taught master's degree run as a day release course for medically qualified candidates who intend to pursue a career in clinical or medical oncology. The overall aim is to encourage proactive problem solving approaches and a reflective approach to medical or clinical oncology practice, producing graduates who are well equipped for leadership careers in twenty-first century oncology.

Find out more about MSc in Oncology

Clinical Academic Training Pathway

For those wishing to follow a clinical academic training path the following opportunities are listed in the order they would be undertaken.

NIHR Academic Clinical Fellowships

The ICR and The Royal Marsden NHS Foundation Trust have a number of Academic Clinical Fellowships available as part of the National Institute for Health and Care Research (NIHR) Integrated Academic Training Programme. These are three-year posts for clinicians in the early stages of specialty training and provide trainees with 25 per cent protected time for research training.

Find out more about NIHR Academic Clinical Fellowships

PhD and MD(Res) for clinicians

There are two options available for clinicians who wish to pursue higher research degrees:

Doctor of Philosophy - PhD

The ICR offers PhD programmes to applicants eligible for full registration or who hold limited registration with the General Medical Council. These three-year fellowships are intended to develop the applicant’s potential to pursue a career as an academic clinician.

Doctor of Medicine (Research) - MD(Res)

The MD(Res) is a research programme specifically designed for clinically-qualified trainees, lasting a minimum of two years (or part-time equivalent). These provide clinical specialists the opportunity to work in a unique multidisciplinary environment alongside world leaders in cancer research and clinicians from The Royal Marsden NHS Foundation Trust.

Find out more about PhD and MD(Res) for clinicians

NIHR Clinical Lectureships

NIHR Clinical Lectureships are aimed at those who are advanced in their specialty training, have completed a research degree and show outstanding potential for continuing a career in academic medicine. Clinical Lectureships allow clinical researchers to spend half of their time undertaking specialist clinical training and half undertaking research training.

Find out more about NIHR Clinical Lectureships

Opportunities for Postdoctoral Clinical fellows

The Emerging Clinical Academic Fellowship scheme, newly launched by CRIS Cancer Foundation and the ICR, offers 2-3 year fellowships to support the development of early postdoctoral-stage clinical researchers.

The programme will help to prepare outstanding clinical researchers to apply for group leader positions – either as a clinician scientist or career development faculty.

Find our more about our Clinical Academic Fellowship scheme

Latest ICR News

A biopsy sample set in wax
Tumour samples from the 1950s could help unlock the mystery of rising bowel cancer cases in the under 50s

07/01/26

Tens of thousands of tumour samples which have been stored in the basement of a London hospital for more than 70 years could be the key to unlocking the mystery of why bowel cancer cases are rising in the under 50s, scientists believe. Researchers at The Institute of Cancer Research, London, and St Marks Hospital are launching a pioneering study to compare bowel cancer specimens from the 1960s with modern-day cancer samples.
Professor Paul Workman
Drug discoverer Paul Workman awarded OBE in New Year’s Honours list

29/12/25

Professor Paul Workman, drug discovery scientist and former Chief Executive of the ICR, has been awarded an OBE in the New Year Honours list 2026 for services to cancer research.
blood test tubes
Blood test could spare men with advanced prostate cancer from futile chemotherapy

22/12/25

New research has identified a way to predict resistance to a cancer drug commonly used to treat advanced prostate cancer.
Microscope image of cells from a human brain tumour
ICR researchers to contribute to £13.7m brain tumour research consortium

19/12/25

The NIHR has announced a £13.7 million investment into research to develop new brain tumour treatments in the UK. The funding will establish the NIHR Brain Tumour Research Consortium – a national partnership uniting hospitals, universities, cancer centres and charities, along with patients. This is a coordinated UK-wide effort, which will involve the ICR's scientists, aims to transform brain cancer treatment.